Blood purification therapy for kidney failure patients on dialysis
Part of Kidney & urinary clinical trials.
This study tests whether adding a special blood-cleaning treatment called hemoperfusion to regular dialysis can improve health outcomes for people with kidney failure. It aims to see if this extra treatment helps patients feel better and live longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been on dialysis for at least 3 months.
- You are 18 years old or older but younger than 85.
- You receive dialysis three times a week.
- You have no remaining kidney function, meaning you produce very little urine (less than 200 ml per day).
- You are willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a long-term, high-flow hemoadsorption therapy for people on maintenance hemodialysis. It aims to see if the treatment can improve outcomes for those with uremia (built-up waste in the blood).
This study compares two advanced dialysis methods to see which one removes waste products from the blood better. If you are already on a type of dialysis called expanded hemodialysis, you might be able to join.
This trial compares two types of dialysis (hemodiafiltration and standard hemodialysis) to see which works better for older adults with kidney failure. You may be eligible if you are over 84, have been on dialysis for at least 3 months, and are generally healthy enough to participate.
This trial tests a special blood-filtering treatment (hemoperfusion) for people with advanced kidney disease on regular dialysis. It aims to remove harmful substances that standard dialysis may not fully clear.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
Hear when a new Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.